author = {Agrawal, Shashank. and Supekar, Bhagyashree. and Wankhade, Vaishali. and Singh, Rajesh.}, title = {{“PRIDE” Complex: A Report of Two Cases}}, journal ={Indian Journal of Drugs in Dermatology}, volume ={5}, number ={1}, pages = {42-45}, doi = {10.4103/ijdd.ijdd_8_19}, year = {2019}, abstract ={ Epidermal growth factor receptor inhibitors are currently widely used for the treatment of nonsmall cell lung cancer and head-and-neck malignancy. These are associated with constellation of cutaneous reactions termed as PRIDE complex which comprises papulopustules and/or paronychia, regulatory abnormalities of hair growth, itching, and dryness. We report two cases of PRIDE complex, diagnosed clinically and histopathologically in patients of nonsmall cell carcinoma of the lung being treated with erlotinib and gefitinib. }, URL ={https://www.ijdd.in/article.asp?issn=2455-3972;year=2019;volume=5;issue=1;spage=42;epage=45;aulast=Agrawal;t=6}, eprint ={https://www.ijdd.in/article.asp?issn=2455-3972;year=2019;volume=5;issue=1;spage=42;epage=45;aulast=Agrawal;t=6} }